Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
/C O R R E C T I O N -- Watson Pharmaceuticals, Inc./
June 25, 2012
from PR Newswire
Research on Mylan Inc. and Watson Pharmaceuticals Inc. - Generic Drug Companies Settling Lawsuits, Releasing New Products
June 25, 2012
from Marketwired News Releases
Watson Announces Completion of New $1.8 Billion Term Loan Facility
June 25, 2012
from PR Newswire
Watson Confirms Favorable Appeals Court Decision in Sanctura XR® Patent Suit
June 18, 2012
from PR Newswire
Calendar of Events - Report Highlights Great Wall Builders Ltd and Watson Pharmaceuticals, Inc.
June 08, 2012
from Marketwired News Releases
Watson to Present at Goldman Sachs Global Healthcare Conference 2012
May 29, 2012
from PR Newswire
Watson Announces Lidoderm® Patent Challenge Settlement
May 29, 2012
- Provides Select Distribution of Endo's Branded Lidoderm® Product Beginning January 1, 2013 - Read More
from PR Newswire
Watson to Present at the Jefferies 2012 Global Healthcare Conference
May 25, 2012
from PR Newswire
Watson Confirms Testim® Patent Challenge
May 24, 2012
- Paragraph IV Litigation Underway - Read More
from PR Newswire
NTRR Orders Initial Manufacturing Run of New pH Balance Formulas
May 22, 2012
from Business Wire News Releases
Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
May 18, 2012
from PR Newswire
Watson Confirms Lo Loestrin® Fe Patent Challenge
May 18, 2012
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Increased Sales Driving Generic Drug Makers Higher
May 15, 2012
from Marketwired News Releases
Watson Confirms Lialda® Patent Challenge
May 09, 2012
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Watson Announces Formation of Global Integration Management Office to Support Pending Actavis Acquisition
May 09, 2012
- Marc Lehnen, Ph.D., Named Senior Vice President, Global Integration Management Read More
from PR Newswire
NTRR: pH Balance Alkalizer May Be Major Contributor to Disease Prevention
May 07, 2012
from Business Wire News Releases
Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 04, 2012
from PR Newswire
Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
May 04, 2012
from PR Newswire
Watson Pharmaceuticals To Webcast Annual Meeting Of Stockholders On May 11, 2012
May 01, 2012
from PR Newswire
Watson First Quarter 2012 Non-GAAP EPS Increases 84% to $1.64; Net Revenue Increases 74% to $1.5 Billion
April 30, 2012
- GAAP EPS $0.43, Compared to $0.36 Q1 2011 - Read More
from PR Newswire
Watson Announces Restructuring of Senior Leadership to Support Expanded Global Businesses
April 27, 2012
- Sigurdur Oli Olafsson Named President, Global Generics Read More
from PR Newswire
QRxPharma's US Commercialisation Partner, Actavis, to be acquired by Watson Pharmaceuticals, Inc.: MoxDuo® IR on track for launch in Q3, 2012
April 26, 2012
from PR Newswire
Watson and Antares Announce the Introduction of Gelnique 3%™, for the Treatment of Overactive Bladder
April 26, 2012
- Gelnique 3%™ Available in US Pharmacies Beginning April 26 -- Read More
from PR Newswire
Watson to Acquire Actavis Group for EUR 4.25 Billion
April 26, 2012
from PR Newswire
Watson to Acquire Actavis Group for EUR 4.25 Billion
April 25, 2012
from Marketwired News Releases
Video: Watson to Acquire Actavis Group for EUR4.25 Billion
April 25, 2012
- Creates 3rd largest global generics company - Read More
from PR Newswire
Watson to Acquire Actavis Group for EUR4.25 Billion
April 25, 2012
- Creates 3rd largest global generics company - Read More
from PR Newswire
Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
April 20, 2012
from PR Newswire
Watson Launches Generic FORTAMET(R)
April 19, 2012
from PR Newswire
Watson Confirms Glumetza® Patent Challenge
April 19, 2012
- Paragraph IV Litigation Underway - Read More
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here